why choose us

First received: September 12, 2022

Clinical Trial: An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lung Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: Positron-Emission Tomography Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

Brief Summary: The phase I/II trial assess the safety and efficacy of a new positron emission tomography (PET) test for early diagnosis of lung cancer.This study uses PET and Me-4FDG new glucose tracer (alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside) designed specifically to determine glucose update into cells in the body.PET is a non-invasive imaging method used to detect cancer in patient.Me4FDG is a radioactive glucose tracer used in PET to locate cells in the body taking up glucose by SGLT2.SLGT2 is a sodium…

Read more